HDAC8 (K33) Antibody

貨號 Cat. No.
BS1167
規格 Size
100μg
品牌 Brand
Bioworld

Description

stock



Host: Rabbit


Reactivity: Human,Mouse,Rat


 



Product


1 mg/ml in Phosphate buffered saline (PBS) with 15 mM sodium azide, approx. pH 7.2.




Purification & Purity


The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen and the purity is > 95% (by SDS-PAGE).




Specificity


HDAC8 (K33) antibody detects endogenous levels of HDAC8 protein.




Applications (Recommended Dilutions)


WB: 1:500~1:1000 IHC: 1:50~1:200






Western Blot(WB)



Western blot (WB) analysis of HDAC8 (K33) antibody in extracts from NIH/3T3 cells.





Immunohistochemistry (IHC)



Immunohistochemistry (IHC) analyzes of HDAC8 (K33) antibody in paraffin-embedded human lung carcinoma tissue.





Storage&Stability


Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.




Background


In the intact cell, DNA closely associates with histones and other nuclear proteins to form chromatin. The remodeling of chromatin is believed to be a critical component of transcriptional regulation and a major source of this remodeling is brought about by the acetylation of nucleosomal histones. Acetylation of lysine residues in the amino terminal tail domain of histone results in an allosteric change in the nucleosomal conformation and an increased accessibility to transcription factors by DNA. Conversely, the deacetylation of histones is associated with transcriptional silencing. Several mammalian proteins have been identified as nuclear histone acetylases, including GCN5, PCAF (p300/CBP-associated factor), p300/CBP, HAT1 and the TFIID subunit TAF II p250. Mammalian HDAC8, isolated from human kidney, is a histone deacetylase that shares homology to other HDACs but has different tissue distribution. HDAC8 is localized to the nucleus and plays a role in the development of a broad range of tissues and in the etiology of cancer.


詢價 / 洽詢此產品

同品牌其他產品

回到產品列表

▲ LINE
諮詢